Sebastian Taetz

Hyaluronic acid-modified DOTAP/DOPE liposomes for the targeted delivery of anti-telomerase siRNA to CD44-expressing lung cancer cells.

Claus-Michael Lehr, Elias Fattal, Silvia Arpicco, 2009, Oligonucleotides.

Biopharmaceutical Characterization of the Telomerase Inhibitor BRACO19

U. Klotz, J. Mueller, C. Lehr, 2006, Pharmaceutical Research.

The influence of chitosan content in cationic chitosan/PLGA nanoparticles on the delivery efficiency of antisense 2'-O-methyl-RNA directed against telomerase in lung cancer cells.

U. Klotz, C. Lehr, H. Huwer, 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Efficient telomerase inhibition in human non-small cell lung cancer cells by liposomal delivery of 2'-O-methyl-RNA.

U. Klotz, C. Lehr, U. Schaefer, 2009, Journal of pharmaceutical sciences.

Decomposition of the telomere-targeting agent BRACO19 in physiological media results in products with decreased inhibitory potential.

U. Klotz, C. Lehr, U. Schaefer, 2008, International journal of pharmaceutics.

Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides.

Claus-Michael Lehr, Marc Schneider, Ulrich F Schaefer, 2007, Nanomedicine : nanotechnology, biology, and medicine.

Optimization of the TRAP assay to evaluate specificity of telomerase inhibitors

U. Klotz, C. Lehr, U. Schaefer, 2005, Laboratory Investigation.

Nanoparticle mediated delivery of 2'-O-methyl-RNA leads to efficient telomerase inhibition and telomere shortening in human lung cancer cells.

U. Klotz, C. Lehr, U. Schaefer, 2010, Lung cancer.